Insider Transactions in Q2 2025 at Summit Therapeutics Inc. (SMMT)
Insider Transaction List (Q2 2025)
Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
---|---|---|---|---|---|
Apr 08
2025
|
Maky Zanganeh Co-Chief Executive Officer |
BUY
Exercise of in-the-money or at-the-money derivatives securities
|
Indirect |
3,985,055
+0.71%
|
$3,985,055
$1.58 P/Share
|
Apr 08
2025
|
Robert W Duggan Co-Chief Executive Officer |
BUY
Exercise of in-the-money or at-the-money derivatives securities
|
Direct |
3,985,055
+0.71%
|
$3,985,055
$1.58 P/Share
|